Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide Krka d.d. (lenalidomide hydrochloride hydrate)

lenalidomide hydrochloride hydrate · Krka, d.d., Novo mesto
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenalidomide Krka d.d. (lenalidomide hydrochloride hydrate), covering 2023-07-10 to 2023-07-10. Get the full timeline:

Most recent: EMA Withdrawn: Lenalidomide Krka d.d. (lenalidomide hydrochloride hydrate) — Krka, d.d., Novo mesto

See pricing